Docket Room
A 4082·NJ·house

Requires registration and regulation of certain hemp-derived cannabinoids manufactured and sold in this State.

In CommitteeFiled Feb 19, 2026
Sponsor: Quijano, Annette
Latest Action

Introduced First Reading Assembly Referred to AOF

Feb 19, 2026

Summary

The bill would obligate manufacturers and retailers of hemp‑derived cannabinoids—such as Delta‑8‑THC foods, supplements, cosmetics and inhalables—to register with the state’s Cannabis Regulatory Commission, submit their products for safety testing, and provide accurate labeling. It targets companies that produce or sell these products in New Jersey to bring them under state oversight and protect consumers. The measure is intended to address the growing unregulated market for psychoactive hemp products.

AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.

Share

Track this bill

Get real-time alerts when A 4082 changes status, plus AI-powered summaries and stage predictions.

Sign up free
Docket Room · Nonpartisan legislative tracking
Docket Room IntelligencePro

Ask about your legislation

I can analyze your tracked bills, upcoming hearings, and recent changes.

AI-generated · Nonpartisan · Not legal advice